 
 
Glenmark Pharmaceuticals Limited 
Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 
T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com 
Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026  E: complianceofficer@glenmarkpharma.com 
 
November 19, 2025 
 
To,      To, 
Dy. General Manager The Manager – Listing,   
Department of Corporate Services,  National Stock Exchange of India Ltd., 
BSE Ltd.,                                           Plot No. C/1, G Block, 
P. J. Towers, Dalal Street,    Bandra Kurla Complex, 
Fort, Mumbai – 400 001    Bandra (E), Mumbai – 400 051 
 
Ref: Scrip Code: 532296    Ref: Scrip Name: GLENMARK 
 
Dear Sirs,  
 
Sub: Transcript of the Earnings Call  
 
Further to our letter dated 6 th November, 2025 and pursuant to Regulation 30(6) read with 
Part A of Schedule III of SEBI (LODR), Regulations 2015, the transcript of the Earnings call held 
on Monday, November 17, 2025 for the second quarter and half year ended September 30, 
2025 has been uploaded on the Company’s website at https://glenmark.b-
cdn.net/gpl_pdfs/investors/reports_presentations/earning_concall/Glenmark-Earnings-
Nov17-2025.pdf.  
 
Request you to kindly take the same on record.  
 
Thanking you. 
  
Yours faithfully, 
For Glenmark Pharmaceuticals Limited 
 
 
 
Harish Kuber  
Company Secretary & Compliance Officer 
 
Tel: 4018 9999 / 4018 9879 
Fax: 4018 9986 (Legal & Secretarial Dept.) 
 
 
